Stocktoria

TransMedics Group, Inc. TMDX

Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2019-05-02
Chart by TradingView
6/9
Piotroski F — financial health
4.04
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$605.5M$441.5M$241.6M$93.5M$30.3M
Gross profit$362.8M$262.1M$154.1M$65.3M$21.2M
Operating income$108.6M$37.5M-$28.7M-$31.4M-$39.4M
Net income$190.3M$35.5M-$25.0M-$36.2M-$44.2M
Operating cash flow$192.8M$48.8M-$13.0M-$45.8M-$28.9M
Free cash flow$133.6M-$80.9M-$164.9M-$57.7M-$32.4M
Total assets$1.1B$804.1M$706.0M$277.1M$134.9M
Total liabilities$595.3M$575.5M$568.8M$89.8M$67.0M
Shareholders' equity$473.1M$228.6M$137.2M$187.4M$67.9M
Ratios
Gross margin59.9%59.4%63.8%69.8%69.9%
Operating margin17.9%8.5%-11.9%-33.6%-130.3%
Net margin31.4%8.0%-10.4%-38.8%-146.1%
FCF margin22.1%-18.3%-68.2%-61.8%-107.0%
Return on assets17.8%4.4%-3.5%-13.1%-32.8%
Return on equity40.2%15.5%-18.2%-19.3%-65.2%
Debt / equity0.31×0.52×
Current ratio7.148.309.3010.665.11
Revenue growth37.1%82.7%158.5%208.8%6.7%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.12,300$1.2M

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 4.04 (safe)

  • Working capital / assets 0.513
  • Retained earnings / assets -0.26
  • EBIT / assets 0.102
  • Equity / liabilities 0.795

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001756262 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.